BRCA1 Immunohistochemistry in a Molecularly Characterized Cohort of Ovarian High-Grade Serous Carcinomas-Reference-Cited by-同舟云学术

BRCA1 Immunohistochemistry in a Molecularly Characterized Cohort of Ovarian High-Grade Serous Carcinomas

Published:2013-01 Issue:1 Volume:37 Page:138-146
ISSN:0147-5185
Container-title:American Journal of Surgical Pathology
language:en
Short-container-title:

Author:

Garg Karuna,Levine Douglas A.,Olvera Narciso,Dao Fanny,Bisogna Maria,Secord Angeles Alvarez,Berchuck Andrew,Cerami Ethan,Schultz Nikolaus,Soslow Robert A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pathology and Forensic Medicine,Surgery,Anatomy

Reference21 articles.

1. Cancer of the ovary.;Cannistra;N Engl J Med,2004

2. Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.;Konstantinopoulos;J Clin Oncol,2010

3. Improved survival in women with BRCA-associated ovarian carcinoma.;Cass;Cancer,2003

4. Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.;Hennessy;J Clin Oncol,2010

5. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability.;Umar;J Natl Cancer Inst,2004

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated Pre-Treatment Systemic Immuno-Inflammatory Indices, Triple-Negative Breast Cancer, and p53 Mutation are Associated with Early-Onset Breast Cancer in Southern Nigeria;2023-11-10

2. BRCA1 expression, its correlation with clinicopathological features, and response to neoadjuvant chemotherapy in high‐grade serous ovarian cancer;Journal of Obstetrics and Gynaecology Research;2023-09-22

3. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis;Cell Death & Disease;2023-08-19

4. Analysis of matched primary and recurrent BRCA1/2 mutation-associated tumors identifies recurrence-specific drivers;Nature Communications;2022-11-07

5. Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers;Cancers;2022-09-28